114 related articles for article (PubMed ID: 27146960)
21. Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO).
Lorenzon L; Parini D; Rega D; Mellano A; Vigorita V; Biondi A; Jaminez-Rosellon R; Scheiterle M; Giannini I; Gallo G; Marino G; Turati L; Marsanic P; De Franco L; Marano L; ; De Luca R
Eur J Surg Oncol; 2017 Aug; 43(8):1472-1480. PubMed ID: 28571778
[TBL] [Abstract][Full Text] [Related]
22. The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy.
Smith FM; Chang KH; Sheahan K; Hyland J; O'Connell PR; Winter DC
Br J Surg; 2012 Jul; 99(7):993-1001. PubMed ID: 22351592
[TBL] [Abstract][Full Text] [Related]
23. Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity.
Ferko A; Orhalmi J; Dusek T; Chobola M; Hovorkova E; Hadzi Nikolov D; Dolejs J
Colorectal Dis; 2015 Oct; 17(10):876-81. PubMed ID: 25808035
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.
Bosch SL; Vermeer TA; West NP; Swellengrebel HA; Marijnen CA; Cats A; Verhoef C; van Lijnschoten I; de Wilt JH; Rutten HJ; Nagtegaal ID
Histopathology; 2016 Nov; 69(5):839-848. PubMed ID: 27270756
[TBL] [Abstract][Full Text] [Related]
25. Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?
Tulchinsky H; Rabau M; Shacham-Shemueli E; Goldman G; Geva R; Inbar M; Klausner JM; Figer A
Ann Surg Oncol; 2006 Mar; 13(3):347-52. PubMed ID: 16450221
[TBL] [Abstract][Full Text] [Related]
26. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
27. High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?
Vallam KC; Engineer R; Desouza A; Patil P; Saklani A
Colorectal Dis; 2016 Oct; 18(10):976-982. PubMed ID: 26362820
[TBL] [Abstract][Full Text] [Related]
28. [Surgical management of patients with pathologic complete response in the primary tumor after neoadjuvant chemotherapy for rectal cancer].
Cui J; Yang L; Guo L; Shao Y; Li N; Zhang H
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):456-60. PubMed ID: 26463151
[TBL] [Abstract][Full Text] [Related]
29. One-level step section histological analysis is insufficient to confirm complete pathological response after neoadjuvant chemoradiation for rectal cancer.
Pereira MA; Dias AR; Faraj SF; Nahas CSR; Imperiale AR; Marques CFS; Cotti GC; Azevedo BC; Nahas SC; de Mello ES; Ribeiro U
Tech Coloproctol; 2017 Sep; 21(9):745-754. PubMed ID: 28819868
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
[TBL] [Abstract][Full Text] [Related]
31. A Systematic Review of Local Excision After Neoadjuvant Therapy for Rectal Cancer: Are ypT0 Tumors the Limit?
Hallam S; Messenger DE; Thomas MG
Dis Colon Rectum; 2016 Oct; 59(10):984-97. PubMed ID: 27602930
[TBL] [Abstract][Full Text] [Related]
32. NEOADJUVANT THERAPY AND SURGERY FOR RECTAL CANCER. Comparative study between partial and complete pathological response.
Andrade VA; Coy CS; Leal RF; Fagundes JJ; Martinez CA; Ayrizono Mde L
Arq Gastroenterol; 2016; 53(3):163-8. PubMed ID: 27438421
[TBL] [Abstract][Full Text] [Related]
33. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?
Habr-Gama A; Perez RO; Proscurshim I; Rawet V; Pereira DD; Sousa AH; Kiss D; Cecconello I
Dis Colon Rectum; 2008 Mar; 51(3):277-83. PubMed ID: 18183463
[TBL] [Abstract][Full Text] [Related]
34. Response to chemoradiotherapy and lymph node involvement in locally advanced rectal cancer.
García-Flórez LJ; Gómez-Álvarez G; Frunza AM; Barneo-Serra L; Fresno-Forcelledo MF
World J Gastrointest Surg; 2015 Sep; 7(9):196-202. PubMed ID: 26425268
[TBL] [Abstract][Full Text] [Related]
35. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
[TBL] [Abstract][Full Text] [Related]
36. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
Lykke J; Jess P; Roikjaer O;
Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
[TBL] [Abstract][Full Text] [Related]
37. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Kuerer HM; Newman LA; Smith TL; Ames FC; Hunt KK; Dhingra K; Theriault RL; Singh G; Binkley SM; Sneige N; Buchholz TA; Ross MI; McNeese MD; Buzdar AU; Hortobagyi GN; Singletary SE
J Clin Oncol; 1999 Feb; 17(2):460-9. PubMed ID: 10080586
[TBL] [Abstract][Full Text] [Related]
38. The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes.
Yegen G; Keskin M; Büyük M; Kunduz E; Balık E; Sağlam EK; Kapran Y; Asoğlu O; Güllüoğlu M
Ann Diagn Pathol; 2016 Feb; 20():29-35. PubMed ID: 26706785
[TBL] [Abstract][Full Text] [Related]
39. [Occult lymph node metastasis in the middle and lower third rectal cancer after neoadjuvant radiotherapy].
Wang HW; Yao YF; Li M; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Mar; 13(3):189-92. PubMed ID: 20336536
[TBL] [Abstract][Full Text] [Related]
40. Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
Wang Q; Yu S; Xiao Z; Liu X; Zhang W; Zhang X; He J; Sun K; Xu T; Feng Q; Zhou Z; Wang L; Yin W
Radiat Oncol; 2015 Jul; 10():142. PubMed ID: 26159510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
